BioSpace News Archive

Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from serious hematologic diseases.

DiaMedica Therapeutics Inc. today announced that Rick Pauls, its President and CEO, will present a corporate overview at the Credit Suisse 31st Annual Healthcare Conference, which will take place November 8 – 10, 2022.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the third quarter of 2022, on Monday, November 7, 2022, before the U.S. financial markets open.

Altoida, Inc today announced that management will be presenting at the upcoming conferences.

Cognito Therapeutics announced today it has been selected to present clinical data from its proprietary gamma sensory stimulation in patients with Alzheimer’s Disease, at the 2022 Clinical Trials in Alzheimer’s Disease (CTAD), held November 29 - December 2, in San Francisco, CA.

This week at CPHI Frankfurt, Thermo Fisher Scientific will showcase its expertise, innovations and capabilities to help pharmaceutical and emerging biotech companies accelerate time to market across a wide range of modalities and platforms, including cell and gene therapies, oral solids, steriles and biologics

Marinus Pharmaceuticals, Inc. today announced that it has entered into a revenue interest financing agreement with Sagard Healthcare Partners for a total of $32.5 million upfront in return for payments based on U.S. net sales of ganaxolone, including the recently approved ZTALMY® (ganaxolone) oral suspension CV.

OMNIVISION and AdaptivEndo™ today announced their partnership to provide a flexible, unified platform for hybrid and single-use endoscopes, including systems used for gastroenterology, hepatology, urology, gynecology, and advanced endoscopic surgery (spinal and cardiac electrophysiology).

Bio-Rad Laboratories, Inc. today announced that the company’s management will participate in a Fireside Chat event during the Credit Suisse 31st Annual Healthcare Conference on Tuesday, November 8, 2022, at 11:00 AM (PST).

Sagimet Biosciences announced today that it will present three abstracts at The Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 4-8, 2022, in Washington, DC.